375 related articles for article (PubMed ID: 3520936)
1. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
2. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
[TBL] [Abstract][Full Text] [Related]
3. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
[TBL] [Abstract][Full Text] [Related]
5. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
[TBL] [Abstract][Full Text] [Related]
6. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
7. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.
Nielsen LS; Hansen JG; Andreasen PA; Skriver L; Danø K; Zeuthen J
EMBO J; 1983; 2(1):115-9. PubMed ID: 11894897
[TBL] [Abstract][Full Text] [Related]
9. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
Nolli ML; Corti A; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):214-8. PubMed ID: 2433787
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
Ding H; Wang JY; Song HY
Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
Schleef RR; Sinha M; Loskutoff DJ
Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
Majidi J; Baradaran B; Hassan ZM; Mostafaie A
Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Lau HK; Kim M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):473-8. PubMed ID: 7841301
[TBL] [Abstract][Full Text] [Related]
16. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
[TBL] [Abstract][Full Text] [Related]
17. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Lindahl T; Wiman B
Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
[TBL] [Abstract][Full Text] [Related]
18. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
Schleef RR; Wagner NV; Loskutoff DJ
J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
[TBL] [Abstract][Full Text] [Related]
19. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
20. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]